Zobrazeno 1 - 10
of 66
pro vyhledávání: '"Simu K. Thomas"'
Autor:
Sigurd Prieur, Lukas Mayerhoff, Jie Zhang, Lennart Hickstein, Simu K. Thomas, Moritz Lehne, Tayyab Salimullah
Publikováno v:
Journal of Comparative Effectiveness Research. 8:121-131
Aim: Quantify hematopoietic stem cell transplantation (HSCT) costs in German patients with acute lymphoblastic leukemia (ALL), diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL). Methods: The primary outcome was direct and indirect co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::245317267756767d5fa5d6fb66ee601b
https://doi.org/10.2217/cer-2018-0100
https://doi.org/10.2217/cer-2018-0100
Autor:
Lufei Tu, Ioannis Tomazos, Thomas O'Connell, Marric Buessing, Scott J. Johnson, Simu K. Thomas
Publikováno v:
PharmacoEconomics. 38(9)
Paroxysmal nocturnal hemoglobinuria, characterized by intravascular hemolysis and venous thrombosis, can be managed with eculizumab, an inhibitor of the complement system; however, patients may periodically experience breakthrough hemolysis. Ravulizu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00d901f5e7aff666eed72911058518b2
https://pubmed.ncbi.nlm.nih.gov/32519233
https://pubmed.ncbi.nlm.nih.gov/32519233
Autor:
Simu K. Thomas, Julie Heroux, Geneviève Gauthier, Lei Chen, Richard T. Maziarz, Annie Guerin, Maryia Zhdanava, Eric Q. Wu
Publikováno v:
International Journal of Hematologic Oncology. 5:63-75
Aim: To assess the 5-year healthcare resource utilization (HRU) and direct payer costs following allogeneic hematopoietic stem cell transplants (HSCTs) in acute lymphoblastic leukemia pediatric patients using data from two large US administrative dat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a8584fc6f027902035bcc9300fc1da2
https://doi.org/10.2217/ijh-2016-0001
https://doi.org/10.2217/ijh-2016-0001
Publikováno v:
Therapeutic innovationregulatory science. 47(5)
This work aimed to provide an understanding of the current use and regulatory acceptability of patient-reported outcome (PRO) measures in labeling claims for central nervous system (CNS) agents. A subset of CNS agents was identified from all New Drug
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::222637eef59b643c1614cf1ae244e0e3
https://pubmed.ncbi.nlm.nih.gov/30235577
https://pubmed.ncbi.nlm.nih.gov/30235577
Autor:
Gordon Fuller, Simu K. Thomas, Kimberley Horspool, Neil Shephard, Marian Knight, Catherine Nelson-Piercy, Steve Goodacre, Beverley J. Hunt, Fiona Lecky
Publikováno v:
Bjog
Objective To identify clinical features associated with pulmonary embolism (PE) diagnosis and determine the accuracy of decision rules and D‐dimer for diagnosing suspected PE in pregnant/postpartum women Design Observational cohort study augmented
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80f0bd3fc8d994c4941d5f8e3432786b
https://pubmed.ncbi.nlm.nih.gov/29873174
https://pubmed.ncbi.nlm.nih.gov/29873174
Autor:
Annie Guerin, Marjolaine Gauthier-Loiselle, Geneviève Gauthier, Lamis K. Eldjerou, Richard T. Maziarz, Yanni Hao, Simu K. Thomas
Publikováno v:
Leukemialymphoma. 59(5)
This study describes short-term and long-term healthcare resource utilization (HRU) and costs following an allogeneic hematopoietic stem cell transplant (HSCT) in adult patients with diffuse large B-cell lymphoma (DLBCL) in a real-world setting. Amon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a160d0f88fa1736d623b4b7b6072919
https://pubmed.ncbi.nlm.nih.gov/28933643
https://pubmed.ncbi.nlm.nih.gov/28933643
Autor:
G Partha, P. Kumar, V. Sonathi, S Bhattacharyya, U. Vudumala, H. Malakar, R. Mahon, S Gupta, Minal Jain, Simu K. Thomas, P Gunda
Publikováno v:
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 17(7)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe84dd3fd36aa4f4c3c5c3e1606b4a8c
https://pubmed.ncbi.nlm.nih.gov/27201854
https://pubmed.ncbi.nlm.nih.gov/27201854
Autor:
V. Sonathi, F. Calado, P.A. Flume, R.M. Shirore, E. Priedane, S Bhattacharyya, C.S. Haworth, Simu K. Thomas
Publikováno v:
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 17(7)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e90556813b4b539d804288fcfa2929d5
https://pubmed.ncbi.nlm.nih.gov/27201797
https://pubmed.ncbi.nlm.nih.gov/27201797
Publikováno v:
PHARMACOECONOMICS
Age-related macular degeneration (AMD) is a leading cause of blindness in people aged >= 50 years. Wet AMD in particular has a major impact on patient quality of life and imposes substantial burdens on healthcare systems. This systematic review exami
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::162dfe40f6ff116dc804da199dd3eb3f
https://doi.org/10.2165/11585520-000000000-00000
https://doi.org/10.2165/11585520-000000000-00000
Publikováno v:
CNS Drugs. 25:53-66
Background: Suboptimal adherence to long-term therapies is common and may potentially have adverse consequences on patient outcomes and healthcare costs. Objective: To assess the association between adherence to levodopa/carbidopa/entacapone therapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2df0a431f05f50176149e257e7eee2f6
https://doi.org/10.2165/11538970-000000000-00000
https://doi.org/10.2165/11538970-000000000-00000